Search

Your search keyword '"Durmaz, Özlem"' showing total 137 results

Search Constraints

Start Over You searched for: Author "Durmaz, Özlem" Remove constraint Author: "Durmaz, Özlem"
137 results on '"Durmaz, Özlem"'

Search Results

3. The role of partial splenic artery embolization in the management of refractory esophageal variceal bleeding due to portal vein thrombosis.

5. The Consequences of HLA Screening in the Prevention of Graft‐Versus‐Host Disease in Living Donor Liver Transplantation.

6. Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

7. Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

9. P1 Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database

10. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency

11. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency

12. Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

13. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency

14. Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

15. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency

16. JAG1 MUTATION SPECTRUM IN CASES WITH ALAGILLE SYNDROME FROM TURKIYE.

17. Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With İnflammatory Bowel Disease: A Multicenter Study

19. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial

21. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial

22. EP1232: ODEVIXIBAT EFFECTS ON CHOLESTASIS-RELATED PARAMETERS: ANALYSIS OF POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

23. Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region

25. Çocukluk Yaş Grubunda Karaciğer Nakli Öncesi ve Sonrası Zayıflatılmış Canlı Aşı Uygulamaları-Türkiye’den Tek Merkez Deneyimi

26. Oral Abstracts

27. THU-289 - Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database

28. THU-284 - Efficacy and safety outcomes with odevixibat treatment: Pooled data from the phase 3 ASSERT and ASSERT-EXT studies in patients with Alagille syndrome

33. Attenuated live vaccine in children with solid organ transplantation on everolimus therapy: Report of two cases.

35. Reliability Of Different Endoscopic Classification Systems In Predicting Pediatric Reflux Esophagitis

36. ESKİ TÜRKÇE VE ÇAĞDAŞ KIPÇAK BAŞKURT, TATAR, KAZAK, KIRGIZ TÜRKÇELERİNDE ʽBİZʼ ZAMİRİ

38. Farklı branşlarda ve cinsiyetteki elit sporcuların imgeleme biçimlerinin incelenmesi

39. Fecal Calprotectin Levels in the Babies with Infantile Colic.

40. Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With İnflammatory Bowel Disease: A Multicenter Study.

41. Mekansal deneyim ve temsilinin çokluduyumsallık bağlamında değerlendirilmesi

42. FRI276 - The phenotype of compound heterozygous BSEP deficiency patients is determined by the combined residual function of the two ABCB11 mutations: results from the NAPPED consortium

45. Kentsel dönüşümün Türkiye'de ki hukuk düzeninde temel haklara etkisi üzerine bir değerlendirme

46. FRI-436-Congenital porto-systemic shunts in children: Preliminary results from the IRCPSS

47. PS-195-Predicting long-term outcome after surgical biliary diversion in Bsep-deficiency patients: Results from the NAPPED consortium

48. Atipik Çölyak Hastalığı ve Eşlik Eden Otoimmün Hepatit

49. Demographic findings of 104 patients with percutaneous endoscopic gastrostomy

50. Çocuk Karaciğer Nakil Alıcılarında Anemi Profili.

Catalog

Books, media, physical & digital resources